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1. Introduction 
The state of the organism is reflected to the key process in the living body - protein 
metabolism. Proteomics is the large-scale study of gene expression at the protein level, 
which will ultimately provide direct measurement of protein expression levels and insight 
into the activity state of all relevant proteins (Pandey & Mann, 2000). The proteome analysis 
usually includes the following strategies: native protein pre-separation, then digestion 
followed by separation and identification, or alternatively straight digestion, separation and 
identification by mass spectrometry. Therefore, starting with one protein, after digestion we 
will end up with approximately 30 to 70 short peptide fragments. Identification of only very 
few of them will provide sufficient information which protein was present in the sample. 
The subproject of proteomics, namely the study of all peptides expressed by a certain cell, 
organ or organism, is termed peptidomics. The term was introduced in 2001 (Clynen et al., 
2003). Peptides often have very specific functions as mediators and indicators of biological 
processes. They play important roles as messengers, e.g., as hormones, growth factors, and 
cytokines, and thus have a high impact on health and disease. Peptidomics comprises not 
only peptides, originally synthesized by an organism to perform a certain task, but also 
degradation products of proteins (degradome). Therefore, proteolytic cleavage of proteins 
leads to peptides as indicators of protease activity, degradation, and degeneration therefore 
it is also reflects the organism state. The sensitivity of proteomics and peptidomics suffers 
from the lack of an amplification method, analogous to the polymerase chain reaction, to 
reveal and quantify the presence of low-abundance proteinaceous constituents therefore the 
display level is difficult. These challenges motivate the researches to develop reliable 
analytical platforms. Shortcomings in throughput are due to the absence of technologies that 
can deliver fast and parallel quantitative analysis of complex peptide distributions in an 
automated fashion. In the future, when peptidomics will be more analyzed and understood, 
and biomarkers identified straight capture step of biomarkers from complex bio-sample 
might be used. Peptidomics especially challenges the need for robust, automated, and 
sensitive high-throughput technologies. Most single-dimension separations lack sufficient 
resolution capability to resolve complex biological matrixes. For example, in human blood 
serum, 90 % of the protein content of serum is composed of 10 basic proteins. The remaining 
10 % of serum consists of trace amounts of millions of different proteins. Thus, partial 
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purification of proteins is necessary so that proteins in trace amounts can be identified and 
their exact structural analysis can be performed. Chromatographic separation techniques are 
well suited for the analysis of complex multi-components samples. To overcome the limited 
peak capacity and concentration diversities of the analytes utilizing chromatographic 
separation systems, multidimensional chromatography (MD-LC) has been realized by 
analyte transfer between different separation modes through automated valve switching 
(Link, 2002). Another important prerequisite for the suitability of separation systems for 
proteomic analysis is the ability to handle very big and very small amounts of biological 
material (Machtejevas et al., 2006). However, the application of several orthogonal LC 
separation systems also bears the danger of severe sample losses due to adsorption on the 
separation and capture column and sample transfer. The mass loadability of LC columns is 
much higher than for 2D-gelelectrophoresis systems and can be tuned to the requirements of 
a MD system. LC modes can be implemented into the sample clean-up which in return 
becomes more selective, robust and reproducible, thus enhancing the quality of the final 
data. The most important feature is however, that MD-LC can be automated with a high 
degree of robustness and reproducibility. 
Most sample-preparation procedures are performed manually and are thus time-consuming 
and laborious. On-line sample clean-up and on-column concentrations avoid this 
disadvantage. There are a number of important features that is gained by having the liquid 
phase separation system to be operated on-line. Direct injection techniques are generally 
preferable, since problems involved in off-line sample pretreatments, such as time 
consuming procedures, errors and risk for low recoveries can be readily avoided. 
Introduction of the Restricted Access Materials (RAM) offers a unique and intelligent 
solution. It designates a support family that allows direct injection of biological fluids by 
limiting the accessibility of interaction sites within the pores to small molecules only. The 
term restricted access material is a general term for a packing material having a 
hydrophobic interior covered by a hydrophilic barrier. The hydrophilic barrier allows 
passage of small molecules to the hydrophobic part of the stationary phase, while sterically 
preventing large molecules, such as proteins, from interacting with this part of the 
stationary phase. Macromolecules are excluded and may interact only with the outer surface 
of the particle support coated with hydrophilic groups, which minimizes the adsorption of 
matrix proteins. 
In a search for new stationary-phase configurations the concept of monolithic silica 
stationary phases was explored and investigated in depth (Unger et al., 2011). A monolith 
consists of a continuous rod, of a rigid, porous polymer, that has no interstitial volume but 
only internal porosity consisting of micro-and macropores. All of the mobile phase is forced 
to flow through the channels of the porous separation medium, resulting in enhanced mass 
transport also improved chromatographic efficiency (Meyers & Liapis, 1999) and 
simultaneous extension of column life time. 
2. Multidimensional LC/MS approaches in proteomics and peptidomics 
Two-dimensional gel electrophoresis (2D-PAGE) and mass spectrometry are well-
established and the most employed techniques in proteomics today. 2D-PAGE, however, 
provides limited information of the total amount of proteins. Low abundant proteins and 
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small peptides are not detected (Issaq, 2001). Additional methodologies and techniques in 
sample preparation, selective enrichment, high resolution separation, and detection need to 
be developed which would allow one to achieve even higher resolution than 2D-PAGE. 
Acceptable sensitivity to detect the low-abundant proteins is also still an issue. LC can 
address some of the above-mentioned problems. In comparison with gel-based separation 
methods, sample handling and preparation are simplified and automated. MD-LC has a 
number of advantages, such as a higher sensitivity, faster analysis time, variable sample 
size (preconcentration of the target substances is possible), possesses a large number of 
separating mechanisms, and, what is most important, and it is amenable to automation. 
However, because of the wide dynamic range, no single chromatographic or 
electrophoretic procedure is likely to resolve a complex mixture of cell or tissue proteins 
and peptides. Liquid chromatographic techniques are fast, quantitative, easy to automate, 
and can be coupled more readily to mass spectrometry than two-dimensional gel 
electrophoresis (Premstaller et al., 2001). The drawback of LC is the limited peak capacity 
of a single column. Thus, multidimensional LC is the choice, fractionating the eluent and 
transfer the fractions between different columns through automated valve switching 
(Cortes, 1990). Mass spectrometry has limitations with respect to sensitivity, therefore, a 
certain number of analyte molecules should be injected in order to be identified. Thus, 
higher amounts of the sample should be applied. Knowing the target analyte 
concentration in the sample provides the answer to the question: how much we should 
inject? In other words, the mass loadability of columns in the multidimensional column 
train plays a significant role, otherwise displacement phenomena and unwanted protein-
protein-interactions will take place, which may change the down-stream composition of 
the individual fractions in an irreproducible way (Willemsen et al., 2004). Another 
important prerequisite for the suitability of a separation system for proteomic analysis is 
the ability to handle very small amounts of biological material (Premstaller et al. 2001). 
These methods allow one to detect low concentrations of peptides from complex mixtures 
with a high degree of automation. 
Multidimensional (multistage, multicolumn) chromatography had been discovered early as 
a powerful tool to separate complex mixtures. Two of the protagonists were J.C. Giddings 
(Giddings, 1984, 1995) and J.F.K. Huber (Huber & Lamprecht, 1995). MD-LC is based on 
coupling columns in an on-line or off-line mode, which are operated in an orthogonal mode, 
i.e. separate the sample mixture by different separation mechanisms. The sample separated 
on the first column (first dimension) is separated into fractions which can then be further 
treated independently of each other. The practical consequence is an enormous gain in peak 
capacity (number of peaks resolved at a given resolution) and the potential of independent 
optimization of the separation conditions for each fraction. Simultaneously, there is the 
option of relative enrichment/depletion and peak compression by fractionation. 
Multidimensional LC separation typically relies on utilizing two or more independent 
physical properties of the peptides to fractionate the mixture into individual components. 
Physical properties commonly exploited include are size, shape, charge, hydrophobicity and 
biomimetic or affinity interactions. These processes are the underlying phenomena for 
peptide/protein separations using different chromatographic modes, such as size exclusion, 
reversed phase, cation/anion exchange and hydrophobic interaction columns. 
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Biological, individual, and variations between individuals (such as gender, age and 
nutrition) affect peptidomes and require careful consideration in order to find valid 
biomarkers. A few, equally important factors for successful proteomic biomarker research 
are high sample quality, high sensitivity, and reproducibility which depend on proper 
selection of the high quality samples.  
While MD-LC MS has found widespread use in the analysis of peptides from natural 
sources or generated by proteolytic digestion of larger proteins, the method is not suitable 
for analyzing proteins directly. First, proteins tend to denature under reversed-phase 
conditions either by stationary phase or mobile phase induced effects (strongly hydrophobic 
surfaces, low pH and high organic solvent concentrations) making their quantitative elution 
rather difficult. Observed recoveries are also often low and life time of the columns is 
compromised. Also, measuring the molecular mass of a protein by MS is not sufficient for its 
unambiguous identification. To circumvent these obstacles the proteins are digested and the 
separation is performed at the peptide level. One can distinguish two approaches (i) 
proteins are separated and then digested (“top-down” proteomics (Wolters et al., 2001)); (ii) 
in “shotgun” proteomics a complex protein mixture is first digested (see Figure 1, a) and 
peptides are then chromatographically resolved (“bottom-up” proteomics (see Figure 1, b) 
(Regnier et al., 2001)). In both cases, separation technologies play a critical role in protein 
identification and analysis. 
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Fig. 1. Liquid chromatography workflow strategy options in proteomics. A – “bottom-up” 
approach, b – “top-down approach”, c – selective sample clean-up directly combined with 
chromatographic separation (“digestion free” strategy), d – direct capture of target 
substances. 
Even though in the “shotgun approach” sample complexity is vastly increased, there are an 
increasing number of reports on the comprehensive analysis of human proteomes using this 
strategy. Prior digestion gives access to the higher molecular weight proteins, however, at 
the expense of rendering the mixture much more complex. Assuming that a given biofluid 
contains 1,000 proteins and that each protein will generate approximately 50 proteolytic 
fragments, we are talking about 50,000 and more peptides to be resolved. This task can only 
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be approached by MD protein identification technologies (Gevaert et al., 2002, Griffin et al., 
2002, Walters et al., 2001, Pang et al., 2002). The disadvantage of this approach is that one 
ends up with an extremely large number of peptides, which need to be resolved. However 
such an approach could be compared to the efforts of virtually to restore the forest look after 
it has been completely milled to the sawdust. No one would ague that this would require a 
lot of guessing and speculations, multiple details might be lost or misinterpreted. 
Another attractive approach is to separate proteins first by ion exchange chromatography 
(see Figure 1 b) according to charge and charge distribution under “soft” (biocompatible) 
conditions and collecting fractions. The fractions are subjected to digestion and consecutive 
re-injection on to a RP column is performed, whereby the separation is based on the 
hydrophobicity. This is particularly favorable since the mobile phase in the second 
dimension (RP) is compatible with the solvent requirements of mass spectrometry. The 
restrictions associated with this method lie in the limited size of proteins that can be 
investigated (MW < 20,000 Daltons) and the insolubility or incomplete separation of very 
hydrophobic peptides. All peptide-containing fractions are then investigated by mass 
spectrometry to generate a peptide map (Schulz-Knappe et al., 2001). This approach has 
already been found to be sufficient to deal with smaller subsets of the proteome (i.e. several 
hundred proteins) (Hille et al., 2001). These studies also clearly demonstrate that this 
methodology is not yet suitable for the analysis of a whole proteome due to its enormous 
complexity. Therefore, pre-selection of the protein from a given tissue or a pre-separation 
seems mandatory. For example, for the analysis of human urine solid-phase extraction (C-18 
packings) to trap peptides, followed by IEX chromatography in the first dimension 
collecting 30 fractions and analysis of the collected fractions by RP LC (C-18) in the second 
dimension (Heine et al., 1997) was successfully employed. A similar procedure was used for 
the separation of proteins and peptides in human plasma filtrate and plasma (Richter et al., 
1999). 
It is easy to be misguided by vast amount of publications usually dealing with standard 
protein digests. Separation of a few digested proteins peptides are shown in Figure 2a. Easy 
to recognize small differences in dynamic range, and even peak distribution, therefore the 
conclusion could be drawn, that all what we need for successful proteomics analysis is high 
peak capacity separation and one dimension then would be sufficient. However, using the 
same chromatographic conditions and column, also injecting eight times more of a real bio-
sample (amniotic fluid) we are not observing nice and even separation any longer (Figure 
2b). This is a common situation with all real bio-samples. 
Direct analysis of biofluids (Figure 1c and d) without prior digestion is a definitive option in 
biomarker discovery peptidomics. Those routes could be accomplished by employing 
restricted access materials. RAM columns possess a dual function: firstly, they operate as 
size-exclusion columns to remove high molecular weight proteins and other undesired 
constituents. The size characteristics of proteins in pure SEC are known to be highly 
dependant on eluent composition such as pH, ionic strength (I) of the buffer (which includes 
salt type and concentration) and on the flow-rate (Quaglia et al., 2006). Ionic strength and 
pH, however, can vary significantly among biofluids such as plasma and urine. The 
consequence will be that the sample cleanup procedures have to be adjusted individually 
with respect to each type of biological sample and standardised protocols have to be worked 
out. Secondly, the RAM column serves as trap or capture column to selectively enrich target 
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Fig. 2. Separation of standard protein digest and real biological sample analysis: upper 
chromatogram - 1 µl BSA digest (1mg/ml), lower chromatogram 8 µl of filtered amniotic 
fluid. Conditions: column - Chromolith Performance RP-18e 100 mm x 2 mm I.D.; eluents - 
A: 95% H2O/5% ACN/0.1% TFA (v/v/v), B: 5% H2O/95% ACN/0.085% TFA (v/v/v); 
gradient - from 5% B to 50% B in 20 min; flow rate - 0.3 ml/min, detection - UV 214 nm. 
compounds in a reversed phase mode or in an ion-exchange mode. By regulating the pore 
size of the particles, the molecular weight exclusion can be varied as well as the molecular 
weight fractionation range, which allows certain analytes to be trapped at the internal 
surface. In this case, only proteins and peptides below a certain molecular shape and size 
have access to the inner pore surface of the RAM, are thus retained while the larger proteins 
encounter only the hydrophilic, non-adsorptive outer surface, and will be flushed out in the 
following washing step. Of the RAM, the strong cation exchanger with sulphonic ligands 
(RAM-SCX) was preferably employed in the sample clean up of proteins, which proved to 
show an acceptable capacity towards positively charged peptides and proteins. The features 
described above, when elegantly combined with column switching, become a powerful tool 
for direct analysis in the profiling of endogeneous peptides in a fully automated, 
multidimensional LC platform. 
www.intechopen.com
 
Profiling of Endogenous Peptides by Multidimensional Liquid Chromatography 
 
231 
2.1 Designing a MD-LC system 
The primary criteria for the choice of a separation phase system are selectivity and 
orthogonality, mass loadability, and biocompatibility (in case of quantitation). As a rule of 
thumb, the first dimension should possess a high mass loadability combined with sufficient 
selectivity and maintenance of bioactivity. Ion exchange chromatography (IEC) therefore is 
the method of choice offering charge selectivity. In principle, there are two options in IEC, 
either to employ a cation or anion exchanger, which in return influences the pH working 
range. Note that either cationic or anionic species are resolved, i.e. only a limited number of 
species from the whole spectrum. The IEC columns are operated via salt gradients with 
increasing ionic strength. Consequently, the salt load must be removed before the fractions 
are transferred to the second dimension column. 
It is most common to use reversed phase chromatography as the second dimension. The 
term RP stands for a number of columns with different degrees of hydrophobicity. The most 
commonly applied phases are n-octadecyl bonded silicas (RP-18 columns). An intrinsic 
feature of RP columns is their desalting property. Salts are eluted at the front of the 
chromatogram, when running a gradient elution with an acidic buffer/acetonitrile mobile 
phase with increasing acetonitrile content. The hydrophobic surface of the RP packing and 
the hydrophobic eluent are not favorable with respect to providing a biocompatible 
environment for proteins: they may change their conformation or denature which may be 
seen by the appearance of broad peaks, splitting of peaks etc. RP columns possess a much 
lower mass loadability than IEC columns (10 mg of protein per gram of packing as 
compared to 100 mg in IEC). An advantage of RP is the fact that the eluents are compatible 
to MS, provided volatile buffers such as ammonium acetate are employed. 
In case of an on-line MD-LC system, the speed of analysis in the second dimension should 
be as high as possible (Wagner et al., 2002). This, however, conflicts with the requirement of 
high resolution or high peak capacity. The highest peak capacity in gradient elution RPC is 
obtained with a shallow gradient at relatively low flow-rate. Thus, a compromise between 
the desired peak capacity and the gradient time is inevitable. Often gradient times of several 
hours are applied for the analysis of peptides from protein digests. 
A question often arising is: How many dimensions do we need in MD-LC? It becomes 
obvious that as the number of dimensions increases, the peak capacity will increase. In an 
ideal case the total peak capacity of the MD-LC system is equal to the product of the 
individual orthogonal dimensions. At the same time, above two dimensions an on-line MD-
LC system becomes very sophisticated in its instrumental setup and may be difficult to 
control. The major goal in proteomics for the common user is to design a highly efficient, 
error minimizing and easy-to-handle system. Reduction of the system complexity is the 
major demand. It is essential to select a minimum number of dimensions to handle complex 
separations which also should preferably include on-line sample clean-up steps. 
2.2 Advantages of on-line sample clean-up approaches 
Most sample-preparation procedures are performed manually and are thus time-consuming 
and laborious. On-line sample clean-up and on-column concentrations avoid this 
disadvantage. There are a number of important features that is gained by having the liquid 
phase separation system to be operated on-line. The overall yield in most cases is improved 
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compared to off-line approaches and methodologies. Exposed surfaces are kept to a 
minimum that usually is the main cause of sample losses. Overall precision can also be 
controlled by having yields above 50 %. It is possible to handle yields that are lower; 
however, it generally is a real analytical challenge to obtain operational stability within such 
analytical processes. Direct injection of samples onto HPLC columns is substantially 
advantageous in the clinical laboratories in terms of its time- and labor-saving capabilities, 
in addition to other advantages given below. General direct injection methods have been 
devised which deal with the problem of many different proteins being present in the 
sample. The methods include the pre-column technique, restricted access materials, and 
chromatography in mobile phases containing surfactant. High performance affinity 
chromatography is also a direct injection technique will demonstrate its power in near 
feature (Figure 1 d). The characteristic and performance of each direct injection technique 
are comprehensively discussed below for the analysis of biological samples. 
The pre-column technique is the direct injection technique that is mostly reported. The pre-
column technique utilizes two columns in series (pre-column and analytical) connected by a 
switching valve. The most common pre-column technique employs a reversed phase pre-
column and a reversed-phase analytical column: the sample is injected into an aqueous 
mobile phase flowing through a pre-column (1-4 cm in length, 3 - 4.6 mm I.D.) which retains 
lipophilic compounds, passing non-retained hydrophilic compounds to waste. The switch in 
valve is then changed and components retained on the pre-column are eluted onto the 
analytical column by increasing the solvent strength of the mobile phase. This technique 
serves the dual function of concentration of analyte and removal of hydrophilic substances. 
There are many advantages of the pre-column injection technique in comparison to 
traditional sample preparation techniques: time saving in comparison to the labor-intensive 
liquid-liquid extraction and precipitation techniques, high reproducibility and high, also a 
superior detection limit capabilities due to its allowance for injection of large sample 
volumes.  
Several types of column-switching designs have been applied. The back flush design is most 
often used because it reduces band broadening (Yamashita et al., 1992). However some 
prefer the forward-flush mode to protect the analytical column from possible impurities at 
the head of the column. Use of an on-line ~0.5µm filter is recommended, which needs 
periodic replacement. A design that incorporates a second pre-column parallel to the first 
has been employed which increases sample throughput, by alternating injection on one pre-
column and back flushing of retained compounds on the other pre-column.  
Most biofluids contain large amounts of well-known proteins such as albumin and IgGs, 
which overwhelm the separation system and make the detection of the low abundant 
proteins and peptides very difficult. It is thus advantageous to remove these proteins prior 
to digestion or direct separation. There are alternative ways of reducing the overall protein 
load by specific adsorption of albumin and IgG to affinity matrices (Nakamura et al., 2002, 
Wang et al., 2003, Govorukhina et al., 2003). While usually an affinity matrix is generally 
highly specific, in high content samples the affinity ligand is limited to exhibit its specificity. 
There are degrees of specificity between highly selective immunoaffinity matrices and less 
selective but more robust affinity supports using synthetic ligands. In an effort to reduce the 
amount of albumin from human serum, a number of affinity matrices has been evaluated 
based on antibodies or dye ligands. Antibody-mediated albumin removal was efficient and 
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selective. Dye ligand chromatography, a technique that is extensively used in protein 
chromatography was surprisingly effective (Andrecht et al., 2004) in particular with regard 
to high binding capacities and a long column lifetime, however, at the expense of selectivity. 
2.3 Restricted access material columns 
The direct injection of biological samples onto the chromatographic column without any 
sample preparation is in most cases highly problematic and may lead to an irreversible 
contamination of the separation columns, which deteriorate selectivity and column 
performance. A powerful asset to circumvent all the named problems is the implementation 
of restricted access material for sample preparation. Special Solid Phase Extraction (SPE) 
supports possessing restricted access properties have been developed (Hagestam and 
Pinkerton, 1985, Yu et al., 1997, Boos and Rudolphi, 1997). In 1991, Desilets et al. (Desilets, et 
al., 1991) introduced the restricted access term. Silica based Restricted Access Materials have 
been developed for the clean-up in bioanalysis; first for low molecular weight compounds in 
biofluids (Rbeida, et al. 2005) and subsequently for biopolymers such as peptides (Wagner et 
al. 2001). Those supports were able to withstand several hundred plasma or serum injections 
(total volume of 5–7 ml) without losing performance. The concept and the methodology 
were successfully used for the sample clean-up of peptides and proteins out of biofluids by 
extending the range of available materials employing cation and anion-exchanger RAM 
(Machtejevas et al., 2004)). Specific non-silica based RAM were also developed for the 
investigation of the food (Bovanova & Brandsteterova 2000) and environmental matrices 
(Hogendoorn et al., 1999). Vijayalakshmi and co-workers (Pitiot et al., 2004) have presented 
a new RAM called a bi-dimensional chromatographic support operating on a size exclusion 
mode and an affinity or pseudoaffinty mode. A survey on the current state-of-art of RAM-
columns in sample pre-treatment is given Souverain et. al. (Souverain et al., 2004). A RAM 
support developed by Boos and Grimm (Boos & Grimm, 1999) is based on SCX-diol 
modification to improve performances in terms of efficiency, retention and reproducibility. 
Račaitytė et al. (Račaitytė et al. 2000) have shown that this type of RAMs is highly suitable 
for the on-line extraction and analysis of neuropeptides in plasma. Machtejevas et al. 
(Machtejevas et al. 2006) analyzed the pore structural parameters and size exclusion 
properties of LiChrospher strong cation-exchange and reverse phase restricted access 
materials. For peptide analysis out of the biofluids, the strong cation-exchange functionality 
seems to be particularly suitable mainly because of the high loadability of the strong cation-
exchange restricted access material (SCX-RAM) and the fact that one can work under non-
denaturing conditions to perform effective chromatographic separations. The proper 
column operating conditions leads to the total effective working time of the RAM column to 
be equal to approximately 500 injections (depending on the type of sample). 
The principle of the restricted access support is based upon the presence of two chemically 
different surface properties of porous silica particles (Figure 3). The outer surface of the 
particles (25 – 40 mm O.D.) is highly biocompatible: it possesses diol modification and hence 
is hydrophilic, while the pore surface chemistry is tailored as a hydrophobic dispersion 
phase with C-18 functionality or as a strong cation exchanger with SO3 functionality. An 
advantage of these adsorbents relies on the simultaneous occurrence of two 
chromatographic separation mechanisms: selective reversed-phase interaction or ion 
exchange chromatography of lower molecular mass analytes and size exclusion 
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chromatography for the macromolecular sample constituents. By regulating the pore size of 
the particles, a physical restriction barrier is adjusted to regulate the interval of molecules 
that may penetrate and, in the case of penetration, may be trapped in the functionalized 
pore structure. A pore size of 6 nm allows access to the pores only for analytes with a 
molecular mass below 15 kDa. The proteins (>15 kDa) can thus be eluted with the void 
volume directly into the waste. Smaller analytes, however, such as drugs and metabolites 
from body fluids, pesticides or hormone residues from milk or animal tissue samples, may 
enter the pores and interact with the n-alkyl chains or ion-exchange groups bound to the 
inside of the pores. When dealing with complex samples i.e. human bio-fluids, the sample 
clean-up and fractionation of the sample into matrix and target analytes can be achieved. 
Depending on the ligands present in the pores, small molecules with hydrophobic or ionic 
properties are selectively enriched. 
 
Fig. 3. Artistic representation of a SCX-RAM silica particle (LiChrospher 60 XDS (SO3/Diol), 
Merck KGaA, Germany). The external surface is coated with hydrophilic, electroneutral 
diol-groups for the exclusion of high molecular weight components (>15 kDa); the internal 
surface is functionalized with ion-exchange groups accessible for low molecular weight 
components which may be trapped by electrostatic interaction. 
The diffusion barrier can be accomplished in two ways: (i) the porous adsorbent particles 
have a topochemically different surface functionalization between the outer particle surface 
and the internal surface. The diffusion barrier is then determined by an entropy controlled 
size exclusion mechanism of the particle depending on the pore size of adsorbent (Pinkerton 
1991); (ii) the diffusion barrier is accomplished by a dense hydrophilic polymer layer with a 
given network size over the essentially functionalized surface. In other words, the diffusion 
barrier is moved as a layer to the interfacial layer inside the adsorbent particles, the 
exclusion properties are controlled by the size of the polymeric network protecting the 
internal surface and is no longer dependant on the average pore diameter of the adsorbent 
(Mazsaroff & Regnier, 1988).  
The SEC process is entropically driven; i.e proteins with decreasing shape and size penetrate 
an increasing volume of the porous particles. The SEC of proteins is commonly carried out 
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with buffer solution containing a high salt concentration, e.g. 0.1 M, at pH 5 to 7. The high 
salt concentration is needed to suppress electrostatic interactions between the solute and the 
charged surface. In the sample clean up of the RAM-SCX column the concentration of salt is 
much lower e.g smaller than 20 mM and the pH is kept at approximately 3. Under these 
conditions, electrostatic attraction forces are dominant between the positively charged 
peptides and proteins whereas the negatively charged species are excluded from the pores 
of the RAM-SCX column through electrostatic repulsion forces (Figure 4 a).  
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Fig. 4. Typical SCX-RAM column separation profile: peaks (a) represent physical exclusion 
by pore size. Trapped retained bio-molecules are separated by a gradient in the second step 
(b). Conditions: column - LiChrospher 60 XDS (SO3/Diol), 25 x 4 mm I.D., flow rate - 0.5 
ml/min, gradient from 0 to 1 M NaCl in 20 mM KH2PO4 pH 2.5, containing 5 % ACN in 30 
min. Sample: 100 μl Human Hemofiltrate (3.7 mg/ml), UV detection at 214 nm. 
After loading the RAM-SCX column the washing step elutes at isocratic conditions all the 
excluded compounds between the start and 15 minutes. After 15 minutes switching occurs 
and the trapped analytes are eluted from the RAM-SCX column with a strong eluent under 
gradient condition in the period between 15 and 45 minutes (Figure 4 b). Thus it is a charge 
and charge distribution selective process combined with SEC. Use of RAM-SCX allows one 
the direct application of biofluids onto the column. Small peptides are selectively trapped in 
the pores by cationic functional groups while large molecular weight biopolymers are 
directed to waste. This strategy performs the sample clean up and selective peptide 
enrichment in one simultaneous step (Figure 1 c).  
Mass loadability of SPE and RAM columns play a key role in executing the sample clean-up. 
It is advisable to work below the overload regime of the column. Otherwise, displacement 
effects and other phenomena such as secondary interaction by adsorbed species might take 
place, which will lead to non-reproducible results (Wilemsen et al., 2004). Last statement is 
particularly important when the task is to monitor medium to low abundant proteins, 
therefore, usually large sample volumes in the millilitre range are applied. As the column 
lifetime is known to be limited a control measure has to be applied to check the condition of 
the RAM-SCX column and, if necessary, replace it by a new one. In our experience the 
column endured about 200 injections of urine. 
Although compatibility of these stationary phases with direct biological sample injection is 
high, one still has to keep in mind that samples have to be filtrated or centrifuged prior to 
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injection to remove the solid contaminants and precipitations. Even so, some components 
tend to agglomerate/precipitate with the time while samples queue up in autosampler. 
Therefore, an additional in-line filter is highly recommended. One should keep in mind that 
the operational flow rate has enormous impact on the molecular size distribution when 
employing a RAM column. Higher flow rates can shift the molecular range of the trapped 
molecules to lower values as smaller molecules need less time to penetrate the pores. Also 
higher flow rates could alter the hydrodynamic volume of the biomolecules. Higher 
molecular mass molecules will be enriched operating at lower flow rates. Column 
temperature affects the viscosity of the mobile phase and, consequently, the diffusion ratio 
and influences the speed of mass transfer. Carefully performed optimizations of the 
chromatographic parameters ensure the success of the analysis. 
2.4 Monolithic silica columns 
Special features of monolithic silica columns circumstanced the successful application in 
proteomics. In contrast to conventional particle-packed columns, monolithic silica columns 
are made of a continuous piece of porous silica, utilizing a sol-gel process leading to rod 
columns, which possess a defined bimodal pore structure with macro and meso pores in the 
micro- and nanometer range (see Figure 5). 
 
Fig. 5. SEM picture of a cross section from a silica monolith. Total porosity > 80%. The 
mesopores form the fine porous structure (average pore size 13 nm) and create the large 
uniform surface area on which adsorption takes place, thereby enabling high performance 
chromatographic separation. The macropores allow rapid flow of the mobile phase at low 
pressure. Their average size is 2 μm. 
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One of the major of those special features is low column backpressure. Low backpressure is 
not only nice to have, but a must, as setting up multidimensional separation platform for 
proteomics it allows one to select a desired flow-rate from a broader range (see Figure 6).  
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Fig. 6. Estimation of monolithic silica columns flow rates and mass loadability per column. 
Columns 2, 3 and 4.6 mm I.D. are 10 cm long; columns 50 µm, 100 µm and 200 µm are 15 cm 
long. 
Prof. Regnier group, demonstrated the advantage of flow rate variation possibility for 4.6 
mm I.D. Chromolith Performance column. It was concluded that silica monolith reversed-
phase chromatography columns show little loss in the resolution of peptides ranging up to 
several thousand in molecular weight as mobile phase velocity is elevated from the 
conventional 2.5–25 mm/s (Xiong et al., 2004). Moreover, at 25 mm/s with a 100 mm length 
column, operating pressure did not exceed 150 bar. This is well within the pressure limit of 
most commercial LC instruments. The separation of a tryptic digest of cytochrome C in 6 
and 60 min seemed almost identical. Resolution at 25 mm/s linear velocity was 77% of that 
at 2.5 mm/s. It was conluded that the fact that peptide separations could be achieved 10 
times faster than with a conventional packed column with moderate loss in resolution could 
have a major impact on analytical throughput in proteomics. 
Combination of different sizes fulfils the injection volume requirement for various samples. 
The possibility of being able to vary the flow-rate over a large area up to very high linear 
flow velocities combined with the robustness of the monoliths also reduce considerably the 
“down times” during washing and re-equilibration of the column (Rieuxet al., 2005). 
Important to notice, that comparing a particulate and a silica monolithic guard column 
showed that the particulate column was clogging much faster than the monolithic column 
(Machtejevas et al., 2007). 120 injections of plasma (50 µl each injection) led to an increase of 
approximately 6 bar at the particulate column back pressure, while at the monolithic column 
the back pressure rise was only approximately 1 bar. The life time of the short silica 
monolithic columns used as a trap column or as a guard column heavily depends on a type 
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and a volume of the bio-fluid injected. After injecting plasma column performance dropped 
drastically when the volume of half column volume was injected. For urine the column 
stability was at least 20 times higher. This is definitely related to the sample complexity. 
Comparing the life time of the same dimension of monolithic silica columns and particle 
packed columns under same conditions; monolithic silica column life time was at least 
double compared with particulate packed column of the similar dimension. This is not a 
surprise, as any particle packed column contains particles and frits to maintain particles in 
the column. The flow through between particles is much smaller that the particle size itself, 
for example, if the column packed with 2 µm particles the space between particles is about 
0.5 µm. Monolithic silica column made as one single spongy rod, does not contains frits, and 
flow through pores (macropores) are about 2 µm diameter. 
Capillary separations, although delivering much improved sensitivity, especially when 
combined with mass spectrometry, often have the drawback of reduced robustness. This is 
partially due to the limited stability of packed capillary columns and the risk of clogging 
(same aspect as discussed above). Monolithic capillary columns made of polymeric (Svec et 
al., 2003) or silica-based materials promise to overcome some of the limitations mentioned 
above, namely that of packing stability. An interesting study was performed by the Guryca 
et. al. to provide a side-by-side comparison of monolithic nano-LC columns used in 
reversed-phase chromatography of proteins tryptic digests (Guryča et al., 2008). They 
compared PepMap (LC Packings, Amsterdam, The Netherlands, 3 μm 100Å, ID 75 μm, 15 
cm), Chromolith CapRod (Merck KGaA, Darmstadt, Germany; silica monolith-C18, ID 100 
μm, 15 cm) and PS-DVB (LC Packings; polystyrene monolith, ID 100 μm, 5 cm) columns (all 
C18 modification), in terms of the number of peptides identified and also with respect to 
their chromatographic characteristics. In terms of performance the peak shapes obtained on 
Chromolith CapRod and PepMap columns appeared to be very similar, and the peak widths 
for both columns were in the range 0.3–0.4 min. The PS-DVB column exhibited somewhat 
disappointing performance which could be attributed, to the mobile phase composition 
used. However, it was concluded, that generally the performance of both silica based 
columns was superior to that of monolithic PS-DVB (Guryča et al., 2008). Also a similar 
finding was observed comparing peptide identification power. Comparing column 
throughput Chromolith CapRod column was superior with 5.0 μl/min in contrast to flow 
rates of up to 0.8 μl/min for PS-DVB column and to 0.5 μl/min for the particulate (PepMap) 
column. Moreover, it was found that, for short gradients, the number of identifications is not 
affected by the flow rate (3–10 mm/s). The results shown demonstrate the greater potential 
of monolithic compared to particle-based columns, as higher flows can be utilized, enabling 
the number of identifications per unit of time to be significantly increased. Furthermore, due 
to their higher porosity they have fewer tendencies to get clogged. Usually, micro columns 
for LC are fabricated by packing beads with a controlled range of diameters and pore sizes. 
To obtain a better efficiency, columns have been packed with particles of ever smaller 
diameters (Szabolcs et al., 2009) bringing about another practical limitation: the increase of 
the back pressure. To circumvent this problem, alternative chromatographic modalities such 
as ultrahigh-pressure liquid chromatography, open tubular chromatography, and capillary 
electro-chromatography have been investigated. All this has led to the use of particle sizes in 
the range of 3 to 5 µm as a good compromise between column efficiency and pressure drop. 
Moreover, it was demonstrated that the recently developed monolithic-type HPLC columns 
could be operated at high flow rates while maintaining a high efficiency. In this context, 
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(Kele & Guiochon, 2002) investigated the reproducibility of the preparation of the first 
columns getting reproducibilities higher than with particle based columns. Because of their 
capacity to perform fast separations they can be used for fast screening methods and 
applications in multidimensional chromatography systems. Conditioning and regeneration 
of these monolithic columns can be done in a short time when compared with the 
corresponding capillary packed columns, thus making more effective use of costly LC-MS 
equipment. They can be easily integrated in fully automated systems to perform unattended 
runs. These columns are flexible and they show a good performance at both low (1.5 
µl/min) and high (4.5 µl/min) flow rates. Such flow rate range is highly compatible with 
MALDI plate spotting strategy. Fraction could be spotted directly, then the flow of 4 µl/min 
allows to spot up to 8 fractions. If the flow rate is set to 3 μl/min, and an equal flow of 
MALDI matrix solution is added post-column (7 mg/ml re-crystallized α-
cyanohydroxycinnamic acid, 2 mg/ml ammonium phosphate, 0.1% trifluoroacetic acid, 80% 
acetonitrile) and the combined eluant is automatically spotted onto a stainless steel MALDI 
target plate every 6 s (0.6 μl/spot), a total of 370 spots obtained per original SCX fraction 
(Fort et al., 2009). Haffey demonstrated similar approach and obtained 3828 MALDI-TOF 
spots from the 12 SCX fractions (Haffey et al., 2009). Such a separation strategy offers 
enormous discrimination power and imposing peak capacity. 
3. Application example: The case study 
The analysis concept is based on an on-line sample preparation and a two-dimensional LC 
(see Figure 7) system: pre-separating the majority of the matrix components from the 
analytes which are retained on a RAM-SCX (LiChrospher 60 XDS (SO3/Diol), two 25 x 4mm  
HP 1100 DAD detector
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HP 1100 Autosampler
HP 1100 Degasser
HP 1100 Bin Pump
MS-MS
RAM-SCX W
W
SCX
C-18
C-18
 
Fig. 7. Multidimensional chromatographic separation platform with integrated on-line 
sample clean-up. 
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id) column followed by a solvent switch and transfer of the trapped peptides using five salt 
steps by mixing 20 mM phosphate buffer (pH 2.5) (eluent A1) and 20 mM phosphate buffer 
with 1.5 M sodium chloride (eluent B1) at following proportions: 85/15; 70/30; 65/45; 
45/55; 0/100 at the constant 0.1 ml/min flow rate was performed after the switching for the 
second dimensional strong cation exchange analytical separation and trapped onto the RP 
column by means of column switching in a way to perform two-dimensional orthogonal 
separations.  
Desorption of the adsorbed species from the RAM-SCX column could be accomplished by 
employing an eluent with a higher solvent strength or pH than the eluent at the loading. We 
preferred the salt steps as the pH needed double time for re-equilibration. The desorption 
step was repeated several times to eliminate memory effects. In order to avoid sample to 
sample cross contamination, two blank gradients were typically applied (with specific 
analytes or higher loadings it could reach up to five blank gradients). The further steps of 
the analysis e.g. the transfer from the RAM-SCX column to the next (analytical cation 
exchange column) is heavily dependant on the way this transfer is performed. Three 
different modes could be chosen to elute the trapped sample from the RAM-SCX column: 
isocratic, one step elution with a strong solvent, elution with a linear gradient and elution 
with pulsed gradient.  
A desalting and preconcentration of the fractions containing proteinaceous components 
were performed on two identical trap columns Zorbax 300 SB-C18, 5 μm particles, 5 x 0.3 
mm I.D. obtained from Agilent (Agilent, Waldbronn, Germany). As a final column a 
monolithic fused silica RP-18 endcapped capillary column of dimensions 150 x 0.1 mm I.D. 
(Chromolith CapRod, Merck KGaA, Darmstadt, Germany) was used. We preferred the 
monolithic type of column over particulate capillary column for the following reasons: (a) 
monolithic silica columns offers high variability of flow rates adjustments, which is 
particularly useful in the set up of multidimensional LC MS system to adjust for different 
column sizes; (b) the monolithic silica columns implemented in the multidimensional LC MS 
system meets the requirement of high reproducibility as with particulate columns; (c) in 
terms of column robustness and usage flexibility monolithic silica columns are superior that 
packed particulate columns eg.: one could cut the top end column when damaged, 
furthermore, there is no change in the permeability as a result of pressure fluctuation; the 
end of the capillary directly connected to the MS; no frits are required etc. Standard 
acetonitrile gradient with 0.1 % formic acid at constant 2 µl/min flow rate separated trapped 
peptides in 40 min. The end of reverse phase capillary column directly inserted in an in 
house made robotic spotting apparatus so that the droplets are accumulated above MALDI 
plate and directed consequently from spot to spot with 2 minute intervals filling 100 spot 
MALDI plate per sample (5 fractions from the RAM-SCX column (salt steps), 20 fractions 
from the monolithic capillary RP 18e column, 5x20=100). After all plate positions were filled 
and dried out properly matrix material, consisting of -cyano-4-hydroxycinamonic acid in 
50 % acetonitrile / 4 % formic acid / water (v/v/v) of a volume of 0.5 µl was spotted on the 
top. The MALDI plate was kept in dark place and analysed within the 12 hours.  
As already mentioned the system performs an on-line directly injected human plasma, 
cerebrospinal fluid and urine sample separation in a fully automated way, by a scale down 
strategy, gaining in sensitivity. In all peptide displays (Figure 8), between 1,000 and 4,000 
mass spectrometric signals appeared, which correspond to 500 – 2,000 individual peptides. 
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This usually reflects redundancy (peptides that elute in more than one fraction), peptide 
species with and without oxidative states, and a small number of mass spectrometric 
derivatives, such as fragment ions. 
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Fig. 8. Example of a human plasma peptide map. Injection volume is 48µl. 
The fully automated 2D-LC system performing an effective fractionation combined with off-
line MALDI TOF MS offers an enormous potential for human peptidomics screening on a 
daily basis. The system offers a high flexibility to be optimized for effective analysis of other 
biofluids such as amniotic fluid, sputum, urine, etc. The systems are completely automated 
and perform a high number of analysis cycles with low cost per analysis. Fast and 
comprehensive mapping of bio peptides and protein fragments will open possibilities to 
recognize novel and specific biomarkers that will help to diagnose disease and possibly 
provide valuable information for new drug development.  
4. Conclusion  
Novel restricted access materials have shown high efficiency in sample clean-up after direct 
on-line biofluid injections. Benefits of monolithic silica columns such as: super eminent low 
backpressure compared to particulate packed columns, therefore high variability of flow 
rates adjustments is possible; superior long term stability and data reproducibility analyzing 
various proteinaceous samples; much higher flow rates allows speeding up the overall 
analysis: fast separation, washing and re-equilibration. When those two novel developments 
are combined in a elegant multidimensional and fully automated way proteomic analysis 
could be accentuated.  
In the future, proteomics will play the major role in drug discovery, accelerating the various 
steps involved – target identification, target validation, drug discovery (efficacy, selectivity 
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and mode of action). Operated on a routine basis, MD-LC may provide with the desired 
data, and after interconnection with the biology outcome could be found. 
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